Format

Send to

Choose Destination
See comment in PubMed Commons below
Curr Urol Rep. 2007 Sep;8(5):419-24.

Repeated botulinum toxin injection for idiopathic overactive bladder: will chemodenervation become a long-term solution?

Abstract

Botulinum toxin A (BTX-A) has emerged as a novel treatment option for idiopathic overactive bladder (OAB) refractory to antimuscarinic agents. The clinical needs of refractory OAB patients have been recently met by sacral neuromodulation and augmentation enterocystoplasty. Important features of BTX-A should include safety, efficacy, and ease of delivery during long-term repeated usage. This article reviews the role of repeated BTX-A injections in the treatment of idiopathic OAB.

PMID:
17880843
[Indexed for MEDLINE]
PubMed Commons home

PubMed Commons

0 comments
How to join PubMed Commons

    Supplemental Content

    Loading ...
    Support Center